These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37650182)

  • 1. [Application of the Chinese Expert Consensus on Diabetes Classification in clinical practice].
    Yang ST; Deng C; He BB; Chen X; Li X; Zhou ZG
    Zhonghua Nei Ke Za Zhi; 2023 Sep; 62(9):1085-1092. PubMed ID: 37650182
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical characteristics and classification diagnosis of newly diagnosed diabetes onset with ketosis or ketoacidosis in adult patients].
    Liu HX; Li GM; Zhou YW; Luo SH; Zheng XY; Yang DZ; Liang H; Yan JH; Yao B; Weng JP
    Zhonghua Yi Xue Za Zhi; 2019 May; 99(18):1369-1374. PubMed ID: 31137122
    [No Abstract]   [Full Text] [Related]  

  • 3. Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus.
    Pan S; Wu T; Shi X; Xie Z; Huang G; Zhou Z
    Endocr J; 2020 Jul; 67(7):793-802. PubMed ID: 32295990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, biochemical, and immunological characteristics of newly diagnosed nonobese diabetic patients aged 18-45 years in China.
    Zhang S; Sun Q; Feng K; Fu Y; Wang O; Ping F; Li Y
    J Diabetes Complications; 2012; 26(1):40-3. PubMed ID: 22226483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin autoantibody could help to screen latent autoimmune diabetes in adults in phenotypic type 2 diabetes mellitus in Chinese.
    Huang G; Wang X; Li Z; Li H; Li X; Zhou Z
    Acta Diabetol; 2012 Oct; 49(5):327-31. PubMed ID: 20473693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea.
    Roh MO; Jung CH; Kim BY; Mok JO; Kim CH
    Acta Diabetol; 2013 Apr; 50(2):129-34. PubMed ID: 20953640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of islet autoantibodies in Thai juvenile-onset type 1 diabetes.
    Trisorus C; Aroonparkmongkol S; Kongmanas HB; Sahakitrungruang T
    Pediatr Int; 2018 Nov; 60(11):1002-1007. PubMed ID: 30151912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics of 261 Cases of Hospitalized Patients with Type 1 Diabetes Mellitus.
    Yang J; Zhou MC; Feng K; Wang O; Zhang HB; Li W; Ping F; Yang J; Li YX
    Chin Med Sci J; 2016 Jun; 31(2):69-75. PubMed ID: 28031093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years.
    Lynam A; McDonald T; Hill A; Dennis J; Oram R; Pearson E; Weedon M; Hattersley A; Owen K; Shields B; Jones A
    BMJ Open; 2019 Sep; 9(9):e031586. PubMed ID: 31558459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.
    Xiang Y; Huang G; Shan Z; Pan L; Luo S; Yang L; Shi L; Li Q; Leslie RD; Zhou Z
    Acta Diabetol; 2015 Dec; 52(6):1121-7. PubMed ID: 26239144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet cell-associated autoantibodies in Ethiopians with diabetes mellitus.
    Siraj ES; Gupta MK; Yifter H; Ahmed A; Kebede T; Reja A; Abdulkadir J
    J Diabetes Complications; 2016 Aug; 30(6):1039-42. PubMed ID: 27220543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Strategy for Islet Autoantibodies in Diabetes Patients of Different Ages.
    Nan X; Li X; Xiang Y; Yan X; Zhou H; Tang X; Cheng J; Niu X; Liu J; Ji Q; Ji L; Huang G; Zhou Z
    Diabetes Technol Ther; 2022 Mar; 24(3):212-219. PubMed ID: 34704825
    [No Abstract]   [Full Text] [Related]  

  • 13. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
    Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Organ-Specific Autoimmunity in Patients With Type 1 Diabetes Mellitus.
    Alam A; Singh SK; Kumar R
    Cureus; 2023 May; 15(5):e38855. PubMed ID: 37303388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet Autoantibody Patterns in Patients With Type 2 Diabetes Aged 60 and Higher: A Cross-Sectional Study in a Chinese Hospital.
    Li R; Huang J; Yu Y; Yang Y
    Front Endocrinol (Lausanne); 2018; 9():260. PubMed ID: 29887833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 diabetes and epilepsy in childhood and adolescence: Do glutamic acid decarboxylase autoantibodies play a role? Data from the German/Austrian/Swiss/Luxembourgian DPV Registry.
    de Sousa GJ; Tittel SR; Häusler M; Holterhus PM; Berger G; Holder M; Kamrath C; Golembowski S; Herrlinger S; Holl RW
    Pediatr Diabetes; 2020 Aug; 21(5):766-773. PubMed ID: 32333480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients.
    Liu J; Bian L; Ji L; Chen Y; Chen H; Gu Y; Ma B; Gu W; Xu X; Shi Y; Wang J; Zhu D; Sun Z; Ma J; Jin H; Shi X; Miao H; Xin B; Zhu Y; Zhang Z; Bu R; Xu L; Shi G; Tang W; Li W; Zhou D; Liang J; Cheng X; Shi B; Dong J; Hu J; Fang C; Zhong S; Yu W; Lu W; Wu C; Qian L; Yu J; Gao J; Fei X; Zhang Q; Wang X; Cui S; Cheng J; Xu N; Wang G; Han G; Xu C; Xie Y; An M; Zhang W; Wang Z; Cai Y; Fu Q; Fu Y; Zheng S; Yang F; Hu Q; Dai H; Jin Y; Zhang Z; Xu K; Li Y; Shen J; Zhou H; He W; Zheng X; Han X; Yu L; She J; Zhang M; Yang T
    Sci China Life Sci; 2016 Sep; 59(9):930-9. PubMed ID: 27225179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and demographic features among patients with type 1 diabetes mellitus in Henan, China.
    Yang L; Yang G; Li X
    BMC Endocr Disord; 2021 Jun; 21(1):131. PubMed ID: 34176476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults.
    Jin P; Huang G; Lin J; Yang L; Xiang B; Zhou W; Zhou Z
    Clin Endocrinol (Oxf); 2011 May; 74(5):587-92. PubMed ID: 21470281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.